PDT Partners, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q2 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
PDT Partners, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2015$1,959,000
-11.8%
21,500
-42.5%
0.05%
-9.3%
Q1 2014$2,221,00037,4110.05%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2014
NameSharesValueWeighting ↓
Consonance Capital Management LP 602,047$61,102,0006.76%
FT Options LLC 36,847$3,740,0005.64%
SCOPIA CAPITAL MANAGEMENT LP 2,988,019$303,254,0004.80%
FT Options LLC 71,000$1,320,0001.99%
Rock Springs Capital Management LP 373,000$37,856,0001.75%
Redmile Group, LLC 338,536$34,358,0001.70%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 362,724$36,813,0001.66%
Ghost Tree Capital, LLC 50,000$5,075,0001.08%
Atika Capital Management LLC 32,500$3,298,0000.95%
Sivik Global Healthcare LLC 25,000$2,537,0000.86%
View complete list of GW PHARMACEUTICALS PLC shareholders